- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06163183
Does Diaphragm Electrical Activity Monitoring Predict Extubation Success in Children?
The Potential of Diaphragm Electrical Activity Monitoring to Predict Extubation Success in Children Requiring Mechanical Ventilation Support Due to Respiratory Failure
Study Overview
Status
Intervention / Treatment
Detailed Description
This prospective observational study included 25 pediatric patients who were intubated due to respiratory failure in the pediatric intensive care unit of the tertiary university-affiliated Marmara University Hospital between August 2014 and July 2015. To conduct the study, we obtained informed consent from the patient's parents and ethical approval from the Marmara University Faculty of Medicine Scientific Research Ethics Committee Board on 06.09.2014. Pediatric patients included which had indication for the insertion of a nasogastric tube (Edi catheter), independent of the study. So Edi catheter had been used instead of nasogastric tube.
When the patients were ready for clinical weaning in accordance with the clinician, the Edi catheter was appropriately inserted into the patients. Then, a spontaneous breathing trial (SBT) was performed and diaphragm activity monitoring was recorded during this process. The patients who met the inclusion criteria switched in a spontaneous breath trial with pressure support ventilation (PSV) or NAVA (Neurally Adjusted Ventilatory Assist) on a Maquet (Solna, Sweden) Servo-i mechanical ventilator for both ventilation modes The patients' demographic and clinical characteristics, mortality scoring, vital parameters (HR, TA, SpO2, RR) and ventilatory parameters (Edi peak, Edi min, FiO2, expiratory Vt), as well as follow-up period were recorded. Arterial/capillary blood gases were taken within the last four hours before extubation and within the first, sixth, 12th, 18th and 24th hours after extubation. If arterial blood gas monitoring was initiated in the patient, arterial monitoring was continued. If capillary blood gas monitoring was initiated, capillary monitoring was continued. Edi data were recorded for at least 24 hours before and after extubation. Edi values were obtained retrospectively from the trend diagram, which provides 24-hour continuous records on the ventilator screen.
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
• Aged between one month and 18 years old
- Intubated for more than 48 hours due to respiratory failure
- Indication for the insertion of a nasogastric tube (Edi catheter), independent of the study
Ready for weaning:
- Normal vital signs for age (fever, heart rate (HR), respiratory rate (RR), tension arterial (TA)
- No catecholamines or sedation drugs
- pH of 7.35 to 7.45
- Positive end expiratory pressure (PEEP) ≤6 mmHg
- Fractionated oxygen (FiO2) ≤0.5
- Oxygen saturation (SpO2) ≥92%
- Vt≥ 5 ml/kg
Exclusion Criteria:
• Contraindication for the insertion of the nasogastric tube (Edi catheter)
- Patients treated with muscle relaxants
- Absence of consent given by the patient's family
- Cases whose Edi levels could not be taken from ventilator's trend diagram due to missing values.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Extubation failure
|
|
|
Extubation success
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm electrical activity (Edi) monitoring
Time Frame: up to 2 days
|
Macquet (servo-i) mechanical ventilator measures the electrical activity (Edi) of the diaphragm (microvolts).
Edi signals are measured using special feeding tubes (Edi catheter) equipped with tiny sensors at the level of gastroesophageal junction.
In the ventilator, Edi trend values can be monitored continuously as 24-hour records.
|
up to 2 days
|
|
Mechanical ventilatory monitoring
Time Frame: up to 2 days
|
ventilatory parameters (Edi peak, Edi min, FiO2), were recorded during the follow up.
|
up to 2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Arterial/capillary blood gases
Time Frame: Arterial/capillary blood gases were taken within the last four hours before extubation and within the first, sixth, 12th, 18th and 24th hours after extubation.
|
If arterial blood gas monitoring was initiated in the patient, arterial monitoring was continued.
If capillary blood gas monitoring was initiated, capillary monitoring was continued.
|
Arterial/capillary blood gases were taken within the last four hours before extubation and within the first, sixth, 12th, 18th and 24th hours after extubation.
|
|
Vital signs ((fever, heart rate (HR), respiratory rate (RR), tension arterial))
Time Frame: up to 2 days
|
Vital signs recorded by pediatric intensive care nurses.
|
up to 2 days
|
|
Expiratory tidal volume
Time Frame: From spontaneous breathing trial until the time for extubation
|
Patients who had >5ml/kg expiratory tidal volume considered to be ready for extubation
|
From spontaneous breathing trial until the time for extubation
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nilufer Yalindag-Ozturk, Proffessor, Marmara University Medical Faculty, Pediatric Intensive Care Speacilist
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1400124188
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatrics
-
Vanderbilt UniversityRita & Alex Hillman FoundationCompleted
-
Fundación para el Fomento de la Investigación Sanitaria...CompletedPediatrics | EchocardiographySpain
-
University of FloridaFogarty International Center of the National Institute of HealthRecruitingTelemedicine | PediatricsHaiti
-
University of CalgaryCompletedHealthy | PediatricsCanada
-
University of CalgaryCompleted
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedPediatrics | Anesthesiology
-
Kasr El Aini HospitalCompleted
-
Johns Hopkins UniversityThe Thomas Wilson Sanitarium for Children of Baltimore CityTerminated
-
Samsung Medical CenterCompletedPediatricsKorea, Republic of
-
Yonsei UniversityUnknown
Clinical Trials on Edi catheter
-
Mount Sinai Hospital, CanadaUnity Health TorontoActive, not recruitingRespiratory Distress Syndrome, Newborn | Infant, PrematureCanada
-
University Hospital of PatrasCompleted
-
Hospices Civils de LyonCompletedPatient-ventilator AsynchronismFrance
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHypertension | Chronic Kidney Diseases | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease, Stage 4 (Severe) | Chronic Kidney Disease, Stage 3 (Moderate)United States
-
University of Alabama at BirminghamRecruitingInfant, Premature, Diseases | Child Development | Infant DevelopmentUnited States
-
ReFlow Medical, Inc.Not yet recruitingCoronary OcclusionUnited States
-
TeleflexRecruitingVascular Access DeviceUnited States
-
University of British ColumbiaCompletedIschemia | Chronic Pain | Phantom Limb Pain | Vascular DiseaseCanada
-
University College Hospital GalwayCompleted
-
University Hospital, Basel, SwitzerlandBoston Scientific CorporationCompleted